Trizivir and Conjunctival hyperaemia - a phase IV clinical study of FDA data

Summary:

Conjunctival hyperaemia is reported only by a few people who take Trizivir.

The phase IV clinical study analyzes which people take Trizivir and have Conjunctival hyperaemia. It is created by eHealthMe based on reports of 2,658 people who have side effects while taking Trizivir from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

2,658 people reported to have side effects when taking Trizivir.
Among them, 3 people (0.11%) have Conjunctival hyperaemia.

What is Trizivir?

Trizivir has active ingredients of abacavir sulfate; lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 2,670 Trizivir users for its effectiveness, alternative drugs and more.

What is Conjunctival hyperaemia?

Conjunctival hyperaemia (congestion of conjunctival vessels) is found to be associated with 901 drugs and 587 conditions by eHealthMe.

Number of Trizivir and Conjunctival hyperaemia reports submitted per year:

Could Trizivir cause Conjunctival hyperaemia?

Time on Trizivir when people have Conjunctival hyperaemia *:

Gender of people who have Conjunctival hyperaemia when taking Trizivir *:

female: 33.33 %
male: 66.67 %

Age of people who have Conjunctival hyperaemia when taking Trizivir *:

Common drugs people take besides Trizivir *:

Viramune: 3 people, 100.00%
Omeprazole: 1 person, 33.33%
Epzicom: 1 person, 33.33%

Common side effects people have besides Conjunctival hyperaemia *:

Cheilitis (infection of lips): 3 people, 100.00%
Rashes (redness): 3 people, 100.00%
Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 100.00%
Swallowing Pain Or Burning: 3 people, 100.00%
Swallowing Difficulty: 3 people, 100.00%
Fever: 3 people, 100.00%
Purpura (purplish discoloration of the skin): 3 people, 100.00%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 3 people, 100.00%
Oral Mucosal Erythema (redness of the mucous membrane of mouth): 2 people, 66.67%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Trizivir and have Conjunctival hyperaemia?

Check whether Conjunctival hyperaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Conjunctival hyperaemia and when was it recovered:

Conjunctival hyperaemia in Trizivir

Expand to all the drugs that have ingredients of abacavir sulfate; lamivudine; zidovudine:

Conjunctival hyperaemia and drugs with ingredients of abacavir sulfate; lamivudine; zidovudine

Alternative drugs to, pros and cons of Trizivir:

Trizivir (2,670 reports)

Common Trizivir side effects:

Fever: 300 reports
Pain: 198 reports
Stress and anxiety: 169 reports
Fatigue (feeling of tiredness): 164 reports

Browse all side effects of Trizivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Conjunctival hyperaemia treatments and more:

Conjunctival hyperaemia (3,821 reports)

COVID vaccines that are related to Conjunctival hyperaemia:

Common drugs associated with Conjunctival hyperaemia:

All the drugs that are associated with Conjunctival hyperaemia:

Conjunctival hyperaemia (901 drugs)

Common conditions associated with Conjunctival hyperaemia:

Glaucoma: 398 reports
Epilepsy: 153 reports
High blood pressure: 147 reports

All the conditions that are associated with Conjunctival hyperaemia:

Conjunctival hyperaemia (587 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; lamivudine; zidovudine (the active ingredients of Trizivir) and Trizivir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.